UBS Downgrades Novartis To Neutral, Sees 'No Meaningful Earnings Growth Expected Before '18'
April 01, 2016 at 09:30 AM EDT
Concerns loom over the prospects of Novartis AG (ADR) (NYSE: NVS), with lack of visibility into Alcon and Entresto. UBS’ ...